πŸ‡ΊπŸ‡Έ FDA
Patent

US 12065428

Anti-viral compounds

granted A61PA61P31/14A61P31/16

Quick answer

US patent 12065428 (Anti-viral compounds) held by Aligos Therapeutics, Inc. expires Mon Aug 15 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Aligos Therapeutics, Inc.
Grant date
Tue Aug 20 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Aug 15 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
23
CPC classes
A61P, A61P31/14, A61P31/16